Intravenous Immunoglobulin Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type, Application, Distribution Channel, End User, and Geography

Description

List of Tables

The Intravenous Immunoglobulin market was valued at US$ 11,206.54 million in 2021 and is expected to reach value of US$ 18,672.55 million by 2028; it is estimated to grow at a CAGR of 7.6% from 2022 to 2028.

Rising prevalence of immunodeficiency diseases and the increasing geriatric population fuel the overall market growth.

According to the National Institute of Allergy and Infectious Diseases (NIAID), over 200 different types of primary immune deficiency diseases (PIDDs) affect about 500,000 people in the US. The rare genetic diseases can be chronic, weak, and expensive to treat. Immune Thrombocytopenia (ITP) is an autoimmune bleeding disorder characterized by abnormally low levels of platelets, a situation referred to as thrombocytopenia. According to the Rare Diseases Organization, around 200,000 ITP cases are recorded worldwide annually. Further, according to the United Nations Population Division, World Population Prospects 2019, Asian and European countries have some of the world's oldest populations aged 65 and over. Japan being at the top with 28%, followed by Italy at 23%. Furthermore, Finland, Portugal, and Greece are among the top five countries with aged population under 22%. Many of the patients treated with IVIG are above the age of 60 years. With aging, the ability to produce T-cells to fight diseases gets significantly reduced. Thus, an older person's body is easily prone to several infections and diseases, which increases the demand for immune therapies that involve the use of IVIg. Thus, the rise in immunodeficiency diseases and the increasing geriatric population globally bolster the growth of the intravenous immunoglobulin market.

Intravenous Immunoglobulin Market: Segmental Overview

Based on the type, the intravenous immunoglobulin market is segmented into IgG, IgM, IgA, IgE, and IgD. The IgG type immunoglobulin segment will hold the largest market share in 2021. However, the handheld segment is anticipated to register the highest CAGR during the forecast period owing to its wide application of IgG in treating several disorders. Based on application, the intravenous immunoglobulin market is segmented into hypogammaglobulinemia, chronic inflammatory demyelinating polyneuropathy, immunodeficiency diseases, myasthenia gravis, multifocal motor neuropathy, idiopathic thrombocytopenic purpura, inflammatory myopathies, specific antibody deficiency, Guillain-Barre syndrome, and others. In 2021, the immunodeficiency diseases segment will likely hold the market's largest share. Moreover, the same segment is expected to witness growth in its demand at the fastest CAGR from 2022 to 2028 due to the rising prevalence of immunodeficiency diseases and increasing FDA approvals for IVIg products to treat immunodeficiency.

Based on distribution channel, the intravenous immunoglobulin market is segmented into hospital pharmacy, retail pharmacy, and others. In 2021, the hospital pharmacy segment held the largest share of the market. However, the retail pharmacy segment is expected to witness growth in its demand at the fastest CAGR from 2022 to 2028, owing to the expansions of retail pharmacies and the shift of consumer behavior towards organized retail pharmacies that offer high-quality drugs and medicines. Based on end user, the intravenous immunoglobulin market is segmented into hospitals, specialty clinics, and others. In 2021, the hospitals segment held the largest share of the market. Further, the specialty clinics segment is expected to witness growth in its demand at the fastest CAGR from 2022 to 2028, owing to the advances in specialty clinics for offering quick and accurate IgRT to patients.

Intravenous Immunoglobulin Market: Geographical Overview

North America holds the largest share of the global intravenous immunoglobulin market, whereas Asia Pacific is the fastest-growing region. The market in North America is expected to grow during the forecast period owing to the rising number of immunodeficiencies and autoimmune diseases, growing research & development activities on IVIg, and rising demand for advanced therapies to treat disease factors propelling the market growth in this region.

During 2022-2028, Asia Pacific is likely to register the highest CAGR in the global intravenous immunoglobulin market. The market in the region is expected to grow significantly in countries, including China, India, and Japan, in the coming years. The Asia Pacific market is expected to grow due to the rising geriatric population, rising prevalence of immune deficiency disorders, and increasing adoption of immunoglobulin-based therapies for the treatment of primary immune deficiencies. Therefore, the region holds huge potential for the intravenous immunoglobulin market players to grow during the forecast period.

Market Opportunities of Intravenous Immunoglobulin Market

The pharmaceutical industry is one of the most R&D intensive industries in the US. The research-based industry allocates around 15-20% of revenues to R&D activities and invests more than US$ 50 billion in R&D annually. The US is the global leader in innovative R&D investments, and the country produced over half of the world's new molecules in the last decade. As per the European Federation of Pharmaceutical Industries and Associations (EFPIA), in 2019, North America accounted for 48.7% of global pharmaceutical sales, compared with 22.9% for Europe. 62.3% of sales of new medicines launched during 2014-2019 were in the US market, which accounted for 18.4% in the European market.

As per the India Brand Equity Foundation (IBEF), India is a major and rising player in the global pharmaceuticals industry. The country is the world's largest trader of generic medications, accounting for about 20% of the worldwide supply by volume. It supplies around 60% of the global vaccination demand. The Indian pharmaceutical industry is worth US$ 42 billion and ranks 3rd in terms of volume and 13th in terms of value across the world. Further, Japan is one of the largest pharmaceutical markets in the world. According to the Ministry of Health, Labor and Welfare (MHLW)'s Annual Pharmaceutical Production Statistics, the Japanese market for prescription and nonprescription pharmaceuticals in 2020 was US$107 billion. Thus, the growing pharmaceutical industry worldwide is likely to create lucrative growth opportunities for the intravenous immunoglobulin market in the coming years.

The World Health Organization (WHO), Globocan, World Bank Data, National Health Service (NHS), National Library of Medicine (NLM), and European Federation of Pharmaceutical Industries and Associations (EFPIA) are a few secondary sources referred to while preparing the report on the global intravenous immunoglobulin market.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the intravenous immunoglobulin market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in the intravenous immunoglobulin market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhancing the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Product Code: TIPRE00004079

1. Introduction

1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
- 1.3.1 Global Intravenous Immunoglobulin Market - By Type
- 1.3.2 Global Intravenous Immunoglobulin Market - By Application
- 1.3.3 Global Intravenous Immunoglobulin Market - By Distribution Channel
- 1.3.4 Global Intravenous Immunoglobulin Market - By End User
- 1.3.5 Global Intravenous Immunoglobulin Market - By Geography

2. Intravenous Immunoglobulin Market- Key Takeaways

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Global Intravenous Immunoglobulin Market - Market Landscape

4.1 Overview
4.2 PEST Analysis
- 4.2.1 North America - PEST Analysis
- 4.2.2 Europe - PEST Analysis
- 4.2.3 Asia Pacific - PEST Analysis
- 4.2.4 South & Central America - PEST Analysis
- 4.2.5 Middle East & Africa - PEST Analysis
4.3 Expert Opinion

5. Intravenous Immunoglobulin Market - Key Market Dynamics

5.1 Market Drivers
- 5.1.1 Rising Prevalence of Immunodeficiency Diseases
- 5.1.2 Increasing Geriatric Population
5.2 Market Restraints
- 5.2.1 Adverse Effects of Immunoglobulin Therapy
5.3 Market Opportunities
- 5.3.1 Growing Pharmaceutical Industry
5.4 Future Trends
- 5.4.1 Strong Pipeline Candidates for IVIG
5.5 Impact Analysis

6. Intravenous Immunoglobulin Market- Global Analysis

6.1 Global Intravenous Immunoglobulin Market Revenue Forecast and Analysis
6.2 Global Intravenous Immunoglobulin Market, By Geography - Forecast and Analysis
6.3 Global Intravenous Immunoglobulin Market - Market Potential Analysis, By Region
6.4 Company Analysis
- 6.4.1 Comparative Company Analysis
- 6.4.2 Growth Strategy Analysis
- 6.4.3 Performance of Key Players
  - 6.4.3.1 Takeda Pharmaceutical Company Limited
  - 6.4.3.2 Grifols, S.A.

7. Global Intravenous Immunoglobulin Market Revenue and Forecast to 2028- by Type

7.1 Overview
7.2 Global Intravenous Immunoglobulin Market, By Type 2022 & 2028 (%)
7.3 IgG
- 7.3.1 Overview
- 7.3.2 IgG Revenue and Forecast to 2028 (US$ Million)
7.4 IgM
- 7.4.1 Overview
- 7.4.2 IgM - Revenue and Forecast to 2028 (US$ Million)
7.5 IgA
- 7.5.1 Overview
- 7.5.2 IgA - Revenue and Forecast to 2028 (US$ Million)
7.6 IgE
- 7.6.1 Overview
- 7.6.2 IgE - Revenue and Forecast to 2028 (US$ Million)
7.7 IgD
- 7.7.1 Overview
- 7.7.2 IgD - Revenue and Forecast to 2028 (US$ Million)

8. Global Intravenous Immunoglobulin Market Revenue and Forecast to 2028 - by Application

8.1 Overview
8.2 Global Intravenous Immunoglobulin Market, By Application 2022 & 2028 (%)
8.3 Hypogammaglobulinemia
- 8.3.1 Overview
- 8.3.2 Hypogammaglobulinemia - Market Revenue and Forecast to 2028 (US$ Million)
8.4 Chronic Inflammatory Demyelinating Polyneuropathy
- 8.4.1 Overview
- 8.4.2 Chronic Inflammatory Demyelinating Polyneuropathy - Market Revenue and Forecast to 2028 (US$ Million)
8.5 Immunodeficiency Diseases
- 8.5.1 Overview
- 8.5.2 Immunodeficiency Diseases - Market Revenue and Forecast to 2028 (US$ Million)
8.6 Myasthenia Gravis
- 8.6.1 Overview
- 8.6.2 Myasthenia Gravis - Market Revenue and Forecast to 2028 (US$ Million)
8.7 Multifocal Motor Neuropathy
- 8.7.1 Overview
- 8.7.2 Multifocal Motor Neuropathy - Market Revenue and Forecast to 2028 (US$ Million)
8.8 Idiopathic Thrombocytopenic Purpura
- 8.8.1 Overview
- 8.8.2 Idiopathic Thrombocytopenic Purpura - Market Revenue and Forecast to 2028 (US$ Million)
8.9 Inflammatory Myopathies
- 8.9.1 Overview
- 8.9.2 Inflammatory Myopathies - Market Revenue and Forecast to 2028 (US$ Million)
8.10 Specific Antibody Deficiency
- 8.10.1 Overview
- 8.10.2 Specific Antibody Deficiency - Market Revenue and Forecast to 2028 (US$ Million)
8.11 Guillain-Barre Syndrome
- 8.11.1 Overview
- 8.11.2 Guillain-Barre Syndrome - Market Revenue and Forecast to 2028 (US$ Million)
8.12 Others
- 8.12.1 Overview
- 8.12.2 Others - Market Revenue and Forecast to 2028 (US$ Million)

9. Global Intravenous Immunoglobulin Market Revenue and Forecast to 2028 - by Distribution Channel

9.1 Overview
9.2 Global Intravenous Immunoglobulin Market, By Distribution Channel 2022 & 2028 (%)
9.3 Hospital Pharmacy
- 9.3.1 Overview
- 9.3.2 Hospital Pharmacy - Market Revenue and Forecast to 2028 (US$ Million)
9.4 Retail Pharmacy
- 9.4.1 Overview
- 9.4.2 Retail Pharmacy - Market Revenue and Forecast to 2028 (US$ Million)
9.5 Others
- 9.5.1 Overview
- 9.5.2 Others - Market Revenue and Forecast to 2028 (US$ Million)

10. Global Intravenous Immunoglobulin Market Revenue and Forecast to 2028 - by End User

10.1 Overview
10.2 Global Intravenous Immunoglobulin Market, By End User 2022 & 2028 (%)
10.3 Hospitals
- 10.3.1 Overview
- 10.3.2 Hospitals - Market Revenue And Forecasts To 2028 (US$ Million)
10.4 Specialty Clinics
- 10.4.1 Overview
- 10.4.2 Specialty Clinics - Market Revenue And Forecasts To 2028 (US$ Million)
10.5 Others
- 10.5.1 Overview
- 10.5.2 Others - Market Revenue And Forecasts To 2028 (US$ Million)

11. Intravenous Immunoglobulin Market Revenue and Forecasts to 2028 - Geographical Analysis

11.1 North America: Intravenous Immunoglobulin Market Revenue and Forecast to 2028
- 11.1.1 Overview
- 11.1.2 North America: Intravenous Immunoglobulin Market - Revenue and Forecast to 2028 (US$ Million)
- 11.1.3 North America: Intravenous Immunoglobulin Market, by Type, 2019-2028 (US$ Million)
- 11.1.4 North America: Intravenous Immunoglobulin Market, by Application, 2019-2028 (US$ Million)
- 11.1.5 North America: Intravenous Immunoglobulin Market, by Distribution Channel, 2019-2028 (US$ Million)
- 11.1.6 North America: Intravenous Immunoglobulin Market, by End User, 2019-2028 (US$ Million)
- 11.1.7 North America: Intravenous Immunoglobulin Market, by Country, 2022 & 2028 (%)
  - 11.1.7.1 US: Intravenous Immunoglobulin Market - Revenue and Forecast to 2028 (US$ Million)
    - 11.1.7.1.1 Overview
    - 11.1.7.1.2 US: Intravenous Immunoglobulin Market - Revenue and Forecast to 2028 (US$ Million)
    - 11.1.7.1.3 US: Intravenous Immunoglobulin Market, by Type, 2019-2028 (US$ Million)
    - 11.1.7.1.4 US: Intravenous Immunoglobulin Market, by Application, 2019-2028 (US$ Million)
    - 11.1.7.1.5 US: Intravenous Immunoglobulin Market, by Distribution Channel, 2019-2028 (US$ Million)
    - 11.1.7.1.6 US: Intravenous Immunoglobulin Market, by End User, 2019-2028 (US$ Million)
  - 11.1.7.2 Canada: Intravenous Immunoglobulin Market - Revenue and Forecast to 2028 (US$ Million)
    - 11.1.7.2.1 Overview
    - 11.1.7.2.2 Canada: Intravenous Immunoglobulin Market - Revenue and Forecast to 2028 (US$ Million)
    - 11.1.7.2.3 Canada: Intravenous Immunoglobulin Market, by Type, 2019-2028 (US$ Million)
    - 11.1.7.2.4 Canada: Intravenous Immunoglobulin Market, by Application, 2019-2028 (US$ Million)
    - 11.1.7.2.5 Canada: Intravenous Immunoglobulin Market, by Distribution Channel, 2019-2028 (US$ Million)
    - 11.1.7.2.6 Canada: Intravenous Immunoglobulin Market, by End User, 2019-2028 (US$ Million)
  - 11.1.7.3 Mexico: Intravenous Immunoglobulin Market - Revenue and Forecast to 2028 (US$ Million)
    - 11.1.7.3.1 Overview
    - 11.1.7.3.2 Mexico: Intravenous Immunoglobulin Market - Revenue and Forecast to 2028 (US$ Million)
    - 11.1.7.3.3 Mexico: Intravenous Immunoglobulin Market, by Type, 2019-2028 (US$ Million)
    - 11.1.7.3.4 Mexico: Intravenous Immunoglobulin Market, by Application, 2019-2028 (US$ Million)
    - 11.1.7.3.5 Mexico: Intravenous Immunoglobulin Market, by Distribution Channel, 2019-2028 (US$ Million)
    - 11.1.7.3.6 Mexico: Intravenous Immunoglobulin Market, by End User, 2019-2028 (US$ Million)
11.2 Europe: Intravenous Immunoglobulin Market Revenue and Forecast to 2028
- 11.2.1 Overview
- 11.2.2 Europe: Intravenous Immunoglobulin Market - Revenue and Forecast to 2028 (US$ Million)
- 11.2.3 Europe: Intravenous Immunoglobulin Market, by Type, 2019-2028 (US$ Million)
- 11.2.4 Europe: Intravenous Immunoglobulin Market, by Application, 2019-2028 (US$ Million)
- 11.2.5 Europe: Intravenous Immunoglobulin Market, by Distribution Channel, 2019-2028 (US$ Million)
- 11.2.6 Europe: Intravenous Immunoglobulin Market, by End User, 2019-2028 (US$ Million)
- 11.2.7 Europe: Intravenous Immunoglobulin Market, by Country, 2022 & 2028 (%)
  - 11.2.7.1 UK: Intravenous Immunoglobulin Market - Revenue and Forecast to 2028 (US$ Million)
    - 11.2.7.1.1 Overview
    - 11.2.7.1.2 UK: Intravenous Immunoglobulin Market - Revenue and Forecast to 2028 (US$ Million)
    - 11.2.7.1.3 UK: Intravenous Immunoglobulin Market, by Type, 2019-2028 (US$ Million)
    - 11.2.7.1.4 UK: Intravenous Immunoglobulin Market, by Application, 2019-2028 (US$ Million)
    - 11.2.7.1.5 UK: Intravenous Immunoglobulin Market, by Distribution Channel, 2019-2028 (US$ Million)
    - 11.2.7.1.6 UK: Intravenous Immunoglobulin Market, by End User, 2019-2028 (US$ Million)
  - 11.2.7.2 Germany: Intravenous Immunoglobulin Market - Revenue and Forecast to 2028 (US$ Million)
    - 11.2.7.2.1 Overview
    - 11.2.7.2.2 Germany: Intravenous Immunoglobulin Market - Revenue and Forecast to 2028 (US$ Million)
    - 11.2.7.2.3 Germany: Intravenous Immunoglobulin Market, by Type, 2019-2028 (US$ Million)
    - 11.2.7.2.4 Germany: Intravenous Immunoglobulin Market, by Application, 2019-2028 (US$ Million)
    - 11.2.7.2.5 Germany: Intravenous Immunoglobulin Market, by Distribution Channel, 2019-2028 (US$ Million)
    - 11.2.7.2.6 Germany: Intravenous Immunoglobulin Market, by End User, 2019-2028 (US$ Million)
  - 11.2.7.3 France: Intravenous Immunoglobulin Market - Revenue and Forecast to 2028 (US$ Million)
    - 11.2.7.3.1 Overview
    - 11.2.7.3.2 France: Intravenous Immunoglobulin Market - Revenue and Forecast to 2028 (US$ Million)
    - 11.2.7.3.3 France: Intravenous Immunoglobulin Market, by Type, 2019-2028 (US$ Million)
    - 11.2.7.3.4 France: Intravenous Immunoglobulin Market, by Application, 2019-2028 (US$ Million)
    - 11.2.7.3.5 France: Intravenous Immunoglobulin Market, by Distribution Channel, 2019-2028 (US$ Million)
    - 11.2.7.3.6 France: Intravenous Immunoglobulin Market, by End User, 2019-2028 (US$ Million)
  - 11.2.7.4 Italy: Intravenous Immunoglobulin Market - Revenue and Forecast to 2028 (US$ Million)
    - 11.2.7.4.1 Overview
    - 11.2.7.4.2 Italy: Intravenous Immunoglobulin Market - Revenue and Forecast to 2028 (US$ Million)
    - 11.2.7.4.3 Italy: Intravenous Immunoglobulin Market, by Type, 2019-2028 (US$ Million)
    - 11.2.7.4.4 Italy: Intravenous Immunoglobulin Market, by Application, 2019-2028 (US$ Million)
    - 11.2.7.4.5 Italy: Intravenous Immunoglobulin Market, by Distribution Channel, 2019-2028 (US$ Million)
    - 11.2.7.4.6 Italy: Intravenous Immunoglobulin Market, by End User, 2019-2028 (US$ Million)
  - 11.2.7.5 Spain: Intravenous Immunoglobulin Market - Revenue and Forecast to 2028 (US$ Million)
    - 11.2.7.5.1 Overview
    - 11.2.7.5.2 Spain: Intravenous Immunoglobulin Market - Revenue and Forecast to 2028 (US$ Million)
    - 11.2.7.5.3 Spain: Intravenous Immunoglobulin Market, by Type, 2019-2028 (US$ Million)
    - 11.2.7.5.4 Spain: Intravenous Immunoglobulin Market, by Application, 2019-2028 (US$ Million)
    - 11.2.7.5.5 Spain: Intravenous Immunoglobulin Market, by Distribution Channel, 2019-2028 (US$ Million)
    - 11.2.7.5.6 Spain: Intravenous Immunoglobulin Market, by End User, 2019-2028 (US$ Million)
  - 11.2.7.6 Rest of Europe: Intravenous Immunoglobulin Market - Revenue and Forecast to 2028 (US$ Million)
    - 11.2.7.6.1 Overview
    - 11.2.7.6.2 Rest of Europe: Intravenous Immunoglobulin Market - Revenue and Forecast to 2028 (US$ Million)
    - 11.2.7.6.3 Rest of Europe: Intravenous Immunoglobulin Market, by Type, 2019-2028 (US$ Million)
    - 11.2.7.6.4 Rest of Europe: Intravenous Immunoglobulin Market, by Application, 2019-2028 (US$ Million)
    - 11.2.7.6.5 Rest of Europe: Intravenous Immunoglobulin Market, by Distribution Channel, 2019-2028 (US$ Million)
    - 11.2.7.6.6 Rest of Europe: Intravenous Immunoglobulin Market, by End User, 2019-2028 (US$ Million)
11.3 Asia Pacific: Intravenous Immunoglobulin Market Revenue and Forecast to 2028
- 11.3.1 Overview
- 11.3.2 Asia Pacific Intravenous Immunoglobulin Market Revenue and Forecasts to 2028 (US$ Million)
- 11.3.3 Asia Pacific: Intravenous Immunoglobulin Market, By Type - 2019-2028 (US$ Million)
- 11.3.4 Asia Pacific: Intravenous Immunoglobulin Market, by Application - 2019-2028 (US$ Million)
- 11.3.5 Asia Pacific: Intravenous Immunoglobulin Market, By Distribution Channel - 2019-2028 (US$ Million)
- 11.3.6 Asia Pacific: Intravenous Immunoglobulin Market, by End User - 2019-2028 (US$ Million)
- 11.3.7 Asia Pacific: Intravenous Immunoglobulin Market, by Country, 2022 & 2028 (%)
  - 11.3.7.1 China: Intravenous Immunoglobulin Market Revenue and Forecasts to 2028 (US$ Million)
    - 11.3.7.1.1 Overview
    - 11.3.7.1.2 China: Intravenous Immunoglobulin Market Revenue and Forecasts to 2028 (US$ Million)
    - 11.3.7.1.3 China: Intravenous Immunoglobulin Market, By Type - 2019-2028 (US$ Million)
    - 11.3.7.1.4 China: Intravenous Immunoglobulin Market, by Application - 2019-2028 (US$ Million)
    - 11.3.7.1.5 China: Intravenous Immunoglobulin Market, By Distribution Channel - 2019-2028 (US$ Million)
    - 11.3.7.1.6 China: Intravenous Immunoglobulin Market, by End User - 2019-2028 (US$ Million)
  - 11.3.7.2 Japan: Intravenous Immunoglobulin Market Revenue and Forecasts to 2028 (US$ Million)
    - 11.3.7.2.1 Overview
    - 11.3.7.2.2 Japan: Intravenous Immunoglobulin Market Revenue and Forecasts to 2028 (US$ Million)
    - 11.3.7.2.3 Japan: Intravenous Immunoglobulin Market, By Type - 2019-2028 (US$ Million)
    - 11.3.7.2.4 Japan: Intravenous Immunoglobulin Market, by Application - 2019-2028 (US$ Million)
    - 11.3.7.2.5 Japan: Intravenous Immunoglobulin Market, By Distribution Channel - 2019-2028 (US$ Million)
    - 11.3.7.2.6 Japan: Intravenous Immunoglobulin Market, by End User - 2019-2028 (US$ Million)
  - 11.3.7.3 India Intravenous Immunoglobulin Market Revenue and Forecasts to 2028 (US$ Million)
    - 11.3.7.3.1 Overview
    - 11.3.7.3.2 India: Intravenous Immunoglobulin Market Revenue and Forecasts to 2028 (US$ Million)
    - 11.3.7.3.3 India: Intravenous Immunoglobulin Market, By Type - 2019-2028 (US$ Million)
    - 11.3.7.3.4 India: Intravenous Immunoglobulin Market, by Application - 2019-2028 (US$ Million)
    - 11.3.7.3.5 India: Intravenous Immunoglobulin Market, By Distribution Channel - 2019-2028 (US$ Million)
    - 11.3.7.3.6 India: Intravenous Immunoglobulin Market, by End User - 2019-2028 (US$ Million)
  - 11.3.7.4 Australia: Intravenous Immunoglobulin Market Revenue and Forecasts to 2028 (US$ Million)
    - 11.3.7.4.1 Overview
    - 11.3.7.4.2 Australia: Intravenous Immunoglobulin Market Revenue and Forecasts to 2028 (US$ Million)
    - 11.3.7.4.3 Australia: Intravenous Immunoglobulin Market, By Type - 2019-2028 (US$ Million)
    - 11.3.7.4.4 Australia: Intravenous Immunoglobulin Market, by Application - 2019-2028 (US$ Million)
    - 11.3.7.4.5 Australia: Intravenous Immunoglobulin Market, By Distribution Channel - 2019-2028 (US$ Million)
    - 11.3.7.4.6 Australia: Intravenous Immunoglobulin Market, by End User - 2019-2028 (US$ Million)
  - 11.3.7.5 South Korea: Intravenous Immunoglobulin Market Revenue and Forecasts to 2028 (US$ Million)
    - 11.3.7.5.1 Overview
    - 11.3.7.5.2 South Korea: Intravenous Immunoglobulin Market Revenue and Forecasts to 2028 (US$ Million)
    - 11.3.7.5.3 South Korea: Intravenous Immunoglobulin Market, By Type - 2019-2028 (US$ Million)
    - 11.3.7.5.4 South Korea: Intravenous Immunoglobulin Market, by Application - 2019-2028 (US$ Million)
    - 11.3.7.5.5 South Korea: Intravenous Immunoglobulin Market, By Distribution Channel - 2019-2028 (US$ Million)
    - 11.3.7.5.6 South Korea: Intravenous Immunoglobulin Market, by End User - 2019-2028 (US$ Million)
  - 11.3.7.6 Rest of Asia Pacific: Intravenous Immunoglobulin Market - Revenue and Forecast to 2028 (US$ Million)
    - 11.3.7.6.1 Overview
    - 11.3.7.6.2 Rest of Asia Pacific: Intravenous Immunoglobulin Market - Revenue and Forecast to 2028 (US$ Million)
    - 11.3.7.6.3 Rest of Asia Pacific: Intravenous Immunoglobulin Market, By Type - 2019-2028 (US$ Million)
    - 11.3.7.6.4 Rest of Asia Pacific: Intravenous Immunoglobulin Market, by Application - 2019-2028 (US$ Million)
    - 11.3.7.6.5 Rest of Asia Pacific: Intravenous Immunoglobulin Market, By Distribution Channel - 2019-2028 (US$ Million)
    - 11.3.7.6.6 Rest of Asia Pacific: Intravenous Immunoglobulin Market, by End User - 2019-2028 (US$ Million)
11.4 South & Central America: Intravenous Immunoglobulin Market
- 11.4.1 Overview
- 11.4.2 South and Central America: Intravenous Immunoglobulin Market - Revenue and Forecast to 2028 (USD Million)
- 11.4.3 South and Central America: Intravenous Immunoglobulin Market, by Type, 2019-2028 (USD Million)
- 11.4.4 South and Central America: Intravenous Immunoglobulin Market, by Application, 2019-2028 (USD Million)
- 11.4.5 South and Central America: Intravenous Immunoglobulin Market, by Distribution Channel, 2019-2028 (USD Million)
- 11.4.6 South and Central America: Intravenous Immunoglobulin Market, by End User, 2019-2028 (USD Million)
- 11.4.7 South and Central America: Intravenous Immunoglobulin Market, by Country, 2022 & 2028 (%)
  - 11.4.7.1 Brazil: Intravenous Immunoglobulin Market - Revenue and Forecast to 2028 (USD Million)
    - 11.4.7.1.1 Overview
    - 11.4.7.1.2 Brazil: Intravenous Immunoglobulin Market - Revenue and Forecast to 2028 (USD Million)
    - 11.4.7.1.3 Brazil: Intravenous Immunoglobulin Market, by Type, 2019-2028 (USD Million)
    - 11.4.7.1.4 Brazil: Intravenous Immunoglobulin Market, by Application, 2019-2028 (USD Million)
    - 11.4.7.1.5 Brazil: Intravenous Immunoglobulin Market, by Distribution Channel, 2019-2028 (USD Million)
    - 11.4.7.1.6 Brazil: Intravenous Immunoglobulin Market, by End User, 2019-2028 (USD Million)
  - 11.4.7.2 Argentina: Intravenous Immunoglobulin Market - Revenue and Forecast to 2028 (USD Million)
    - 11.4.7.2.1 Overview
    - 11.4.7.2.2 Argentina: Intravenous Immunoglobulin Market - Revenue and Forecast to 2028 (USD Million)
    - 11.4.7.2.3 Argentina: Intravenous Immunoglobulin Market, by Type, 2019-2028 (USD Million)
    - 11.4.7.2.4 Argentina: Intravenous Immunoglobulin Market, by Application, 2019-2028 (USD Million)
    - 11.4.7.2.5 Argentina: Intravenous Immunoglobulin Market, by Distribution Channel, 2019-2028 (USD Million)
    - 11.4.7.2.6 Argentina: Intravenous Immunoglobulin Market, by End User, 2019-2028 (USD Million)
  - 11.4.7.3 Rest of South and Central America: Intravenous Immunoglobulin Market - Revenue and Forecast to 2028 (USD Million)
    - 11.4.7.3.1 Overview
    - 11.4.7.3.2 Rest of South and Central America: Intravenous Immunoglobulin Market - Revenue and Forecast to 2028 (USD Million)
    - 11.4.7.3.3 Rest of South and Central America: Intravenous Immunoglobulin Market, by Type, 2019-2028 (USD Million)
    - 11.4.7.3.4 Rest of South and Central America: Intravenous Immunoglobulin Market, by Application, 2019-2028 (USD Million)
    - 11.4.7.3.5 Rest of South and Central America: Intravenous Immunoglobulin Market, by Distribution Channel, 2019-2028 (USD Million)
    - 11.4.7.3.6 Rest of South and Central America: Intravenous Immunoglobulin Market, by End User, 2019-2028 (USD Million)
11.5 Middle East & Africa Intravenous Immunoglobulin Market
- 11.5.1 Overview
- 11.5.2 Middle East & Africa: Intravenous Immunoglobulin Market Revenue and Forecast to 2028 (US$ Million)
- 11.5.3 Middle East & Africa: Intravenous Immunoglobulin Market Revenue and Forecast to 2028, by Type (US$ Million)
- 11.5.4 Middle East & Africa: Intravenous Immunoglobulin Market Revenue and Forecast to 2028, by Application (US$ Million)
- 11.5.5 Middle East & Africa: Intravenous Immunoglobulin Market Revenue and Forecast to 2028, by Distribution Channel (US$ Million)
- 11.5.6 Middle East & Africa: Intravenous Immunoglobulin Market Revenue and Forecast to 2028, by End User (US$ Million)
- 11.5.7 Middle East & Africa Intravenous Immunoglobulin Market Revenue and Forecast to 2028, by Country (%)
  - 11.5.7.1 Saudi Arabia: Intravenous Immunoglobulin Market - Revenue and Forecast to 2028 (USD Million)
    - 11.5.7.1.1 Overview
    - 11.5.7.1.2 Saudi Arabia Intravenous Immunoglobulin Market Revenue and Forecast to 2028 (US$ Million)
    - 11.5.7.1.3 Saudi Arabia: Intravenous Immunoglobulin Market Revenue and Forecast to 2028, By Type (US$ Million)
    - 11.5.7.1.4 Saudi Arabia: Intravenous Immunoglobulin Market Revenue and Forecast To 2028, By Application (US$ Million)
    - 11.5.7.1.5 Saudi Arabia: Intravenous Immunoglobulin Market Revenue and Forecast to 2028, By Distribution Channel (US$ Million)
    - 11.5.7.1.6 Saudi Arabia: Intravenous Immunoglobulin Market Revenue and Forecast To 2028, By End User (US$ Million)
  - 11.5.7.2 South Africa: Intravenous Immunoglobulin Market - Revenue and Forecast to 2028 (USD Million)
    - 11.5.7.2.1 Overview
    - 11.5.7.2.2 South Africa: Intravenous Immunoglobulin Market Revenue and Forecast to 2028 (US$ Million)
    - 11.5.7.2.3 South Africa: Intravenous Immunoglobulin Market Revenue and Forecast to 2028, By Type (US$ Million)
    - 11.5.7.2.4 South Africa: Intravenous Immunoglobulin Market Revenue and Forecast To 2028, By Application (US$ Million)
    - 11.5.7.2.5 South Africa: Intravenous Immunoglobulin Market Revenue and Forecast To 2028, By Distribution Channel (US$ Million)
    - 11.5.7.2.6 South Africa: Intravenous Immunoglobulin Market Revenue and Forecast To 2028, By End User (US$ Million)
  - 11.5.7.3 UAE: Intravenous Immunoglobulin Market - Revenue and Forecast to 2028 (USD Million)
    - 11.5.7.3.1 Overview
    - 11.5.7.3.2 UAE: Intravenous Immunoglobulin Market Revenue and Forecast to 2028 (US$ Million)
    - 11.5.7.3.3 UAE: Intravenous Immunoglobulin Market Revenue and Forecast to 2028, By Type (US$ Million)
    - 11.5.7.3.4 UAE: Intravenous Immunoglobulin Market Revenue and Forecast To 2028, By Application (US$ Million)
    - 11.5.7.3.5 UAE: Intravenous Immunoglobulin Market Revenue and Forecast To 2028, By Distribution Channel (US$ Million)
    - 11.5.7.3.6 UAE: Intravenous Immunoglobulin Market Revenue and Forecast To 2028, By End User (US$ Million)
  - 11.5.7.4 Rest of the Middle East and Africa: Intravenous Immunoglobulin Market - Revenue and Forecast to 2028 (USD Million)
    - 11.5.7.4.1 Overview
    - 11.5.7.4.2 Rest of the Middle East and Africa Intravenous Immunoglobulin Market Revenue and Forecast to 2028 (US$ Million)
    - 11.5.7.4.3 Rest of the Middle East and Africa: Intravenous Immunoglobulin Market Revenue and Forecast to 2028, By Type (US$ Million)
    - 11.5.7.4.4 Rest of the Middle East and Africa: Intravenous Immunoglobulin Market Revenue and Forecast To 2028, By Application (US$ Million)
    - 11.5.7.4.5 Rest of the Middle East and Africa: Intravenous Immunoglobulin Market Revenue and Forecast To 2028, By Distribution Channel (US$ Million)
    - 11.5.7.4.6 Rest of the Middle East and Africa: Intravenous Immunoglobulin Market Revenue and Forecast To 2028, By End User (US$ Million)

12. Impact of COVID-19 Pandemic on Intravenous Immunoglobulin Market

12.1 North America: Impact Assessment of COVID-19 Pandemic
12.2 Europe: Impact Assessment of COVID-19 Pandemic
12.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
12.4 South and Central America: Impact Assessment of COVID-19 Pandemic
12.5 Middle East and Africa: Impact Assessment of COVID-19 Pandemic

13. Intravenous Immunoglobulin Market-Industry Landscape

13.1 Overview
13.2 Growth Strategies in the Intravenous Immunoglobulin Market
13.3 Inorganic Growth Strategies
- 13.3.1 Overview
13.4 Organic Growth Strategies
- 13.4.1 Overview

14. Company Profiles

14.1 Takeda Pharmaceutical Company Limited
- 14.1.1 Key Facts
- 14.1.2 Business Description
- 14.1.3 Products and Services
- 14.1.4 Financial Overview
- 14.1.5 SWOT Analysis
- 14.1.6 Key Developments
14.2 Grifols, S.A.
- 14.2.1 Key Facts
- 14.2.2 Business Description
- 14.2.3 Products and Services
- 14.2.4 Financial Overview
- 14.2.5 SWOT Analysis
- 14.2.6 Key Developments
14.3 Pfizer Inc.
- 14.3.1 Key Facts
- 14.3.2 Business Description
- 14.3.3 Products and Services
- 14.3.4 Financial Overview
- 14.3.5 SWOT Analysis
- 14.3.6 Key Developments
14.4 ADMA Biologics, Inc.
- 14.4.1 Key Facts
- 14.4.2 Business Description
- 14.4.3 Products and Services
- 14.4.4 Financial Overview
- 14.4.5 SWOT Analysis
- 14.4.6 Key Developments
14.5 Bio Products Laboratory Ltd.
- 14.5.1 Key Facts
- 14.5.2 Business Description
- 14.5.3 Products and Services
- 14.5.4 Financial Overview
- 14.5.5 SWOT Analysis
- 14.5.6 Key Developments
14.6 Shanghai RAAS
- 14.6.1 Key Facts
- 14.6.2 Business Description
- 14.6.3 Products and Services
- 14.6.4 Financial Overview
- 14.6.5 SWOT Analysis
- 14.6.6 Key Developments
14.7 Octapharma AG
- 14.7.1 Key Facts
- 14.7.2 Business Description
- 14.7.3 Products and Services
- 14.7.4 Financial Overview
- 14.7.5 SWOT Analysis
- 14.7.6 Key Developments
14.8 Kedrion S.p.A
- 14.8.1 Key Facts
- 14.8.2 Business Description
- 14.8.3 Products and Services
- 14.8.4 Financial Overview
- 14.8.5 SWOT Analysis
- 14.8.6 Key Developments
14.9 CSL Behring (CSL Limited)
- 14.9.1 Key Facts
- 14.9.2 Business Description
- 14.9.3 Products and Services
- 14.9.4 Financial Overview
- 14.9.5 SWOT Analysis
- 14.9.6 Key Developments
14.10 Prothya Biosolutions B.V.
- 14.10.1 Key Facts
- 14.10.2 Business Description
- 14.10.3 Products and Services
- 14.10.4 Financial Overview
- 14.10.5 SWOT Analysis
- 14.10.6 Key Developments

15. Appendix

15.1 About The Insight Partners
15.2 Glossary of Terms in Intravenous Immunoglobulin Market